Clinical Trials Logo

Cholangiocarcinoma Metastatic clinical trials

View clinical trials related to Cholangiocarcinoma Metastatic.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03043547 Completed - Clinical trials for Cholangiocarcinoma Non-resectable

Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies

NALIRICC
Start date: October 24, 2017
Phase: Phase 2
Study type: Interventional

is an open label, randomized, multicenter phase II trial